本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ascendis Pharma A/S

227.00
-2.2300-0.97%
盘后:227.000.00000.00%19:30 EDT
成交量:66.74万
成交额:1.52亿
市值:150.25亿
市盈率:17.30
高:229.23
开:229.00
低:226.66
收:229.23
52周最高:282.15
52周最低:186.05
股本:6,618.99万
流通股本:6,553.95万
量比:0.75
换手率:1.02%
股息:- -
股息率:- -
每股收益(TTM):13.12
每股收益(LYR):-4.4176
净资产收益率:118.78%
总资产收益率:9.58%
市净率:9.36
市盈率(LYR):-51.39

数据加载中...

2026/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities